I am a
Home I AM A Search Login

Papers of the Week

Papers: 10 Sep 2022 - 16 Sep 2022

Human Studies

2022 Nov

Lancet Reg Health Eur


SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study.


Frahm N, Fneish F, Ellenberger D, Haas J, Loebermann M, Parciak T, Peters M, Pöhlau D, Rodgers J, Röper A-L, Schilling S, Stahmann A, Temmes H, Zettl UK, Middleton RM
Lancet Reg Health Eur. 2022 Nov; 22:100502.
PMID: 36090519.


Vaccines offer people with multiple sclerosis (PwMS) an effective protection against severe COVID-19 disease courses. However, representative real-world data on the tolerability of SARS-CoV-2 vaccines in PwMS are limited. We aimed at analysing vaccination reactions (VRs) and MS deterioration following SARS-CoV-2 vaccinations in German and United Kingdom (UK) PwMS, especially regarding gender-specific differences.